International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

740 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-05-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the present study is to describe patient's perception of quality of life and effectiveness of ORALAIR® over a follow-up period up to 5 years, in real-life settings.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

NCT02295969

Allergy

COMPLETED

Efficacy and Safety of Grass Pollen Sublingual Immunotherapy

NCT00567346

Allergic Rhinoconjunctivitis

COMPLETED PHASE2/PHASE3

Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis

NCT02014623

Allergic Rhinitis

COMPLETED PHASE4

Long-term Efficacy and Safety Study With Oralgen Grass Pollen

NCT00824447

Allergic Rhinoconjunctivitis

COMPLETED PHASE2/PHASE3

The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)

NCT00092118

Rhinitis, Allergic, Perennial

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary objective:

To describe the patient's perception of the impact of ORALAIR® on his/her health related generic and disease specific quality of life during the grass pollen season in real-life settings.

Secondary objectives:

\- To describe the patient's perceived effectiveness of ORALAIR® in allergic rhinoconjunctivitis management in terms of disease intensity, satisfaction and rescue medication

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Allergic Rhinitis Due to Grass Pollens

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

allergic rhino-conjunctivitis

Patient with proven allergic rhino-conjunctivitis due to grass pollen

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient of 5 years of age and older at the date of the screening visit
* Patient with proven allergic rhino-conjunctivitis due to grass pollen
* Patient eligible for a grass-pollen Allergen ImmunoTherapy (AIT)
* Patient whose physician prescribed ORALAIR® independently of the study, before the beginning of the grass-pollen season